Trending Markets Today
Today's Wisdom
"Build multiple streams of income. "
— Robert AllenExplore Markets
Latest Market Insights
Stock Indexes Settle Sharply Lower on Big Tech Drubbing
The S&P 500 Index ($SPX ) (SPY ) closed down -1.92% on Monday, the Dow Jones Industrial Average ($DOWI ) (DIA ) closed down -1.41%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed down -2.67%. December E-mini S&P futures (ESZ26 ) fell -1.91%, and December E-mini Nasdaq futures...
Strategy Inc Announces ATM Sales of 2,087,040 Class A Shares and Purchase of 485 Bitcoin
Strategy Inc announced updates regarding its at-the-market offering program, bitcoin holdings, share repurchases, and dividend declarations. During the period from November 9, 2026 to November 15, 2026, the company sold 2,087,040 shares of Class A Common Stock. According to the c
Jasper Therapeutics, Inc. Reports Third Quarter 2026 Financial Results and Clinical Pipeline Progress
Jasper Therapeutics, Inc. reported its financial results for the fiscal quarter ended September 30, 2026, and provided a corporate update. Cash and cash equivalents as of September 30, 2026, totaled $135.3 million. Research and development expense for the three months ended Septe
Relmada Therapeutics, Inc. Appoints Jørn Skibsted Jakobsen, MD, PhD, as Chief Development Officer
Relmada Therapeutics, Inc. announced the appointment of Jørn Skibsted Jakobsen, MD, PhD, as Chief Development Officer, Urology & Uro-Oncology, on November 16, 2026. Dr. Jakobsen will lead clinical development across the company's pipeline, including the planned Phase 3